FDA Adverse Event Malfunction Summary report: N

NC TREK CORONARY DILATATION CATHETER

MDR report key: 8287626 · Received January 29, 2019

Report

Report Number
2024168-2019-00658
Event Type
Malfunction
Date Received
January 29, 2019
Date of Event
January 15, 2019
Report Date
January 29, 2019
Manufacturer
AV-TEMECULA-CT
Product Code
LOX
UDI-DI
08717648151910
PMA / PMN Number
K110134
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. CONCOMITANT MEDICAL PRODUCTS: GUIDE WIRE: SION BLUE. GUIDE CATHETER: HYPERION 6FR SPB, 3.5 OPTICROSS. THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO MANUFACTURING NONCONFORMITIES THAT WOULD HAVE CONTRIBUTED TO THIS COMPLAINT. ADDITIONALLY, A REVIEW OF THE COMPLAINT HISTORY DID NOT INDICATE A LOT SPECIFIC QUALITY ISSUE. THE INVESTIGATION DETERMINED THE REPORTED BALLOON RUPTURE APPEARS TO BE RELATED TO ANATOMICAL CONDITIONS. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A 90% STENOSED LESION IN THE PROXIMAL LEFT CIRCUMFLEX CORONARY ARTERY. DURING ADVANCEMENT OF THE 3.25X8 MM NC TREK RX BALLOON DILATATION CATHETER (BDC), RESISTANCE WAS NOTED WITH THE ANATOMY. THE BDC RUPTURED DURING THE FIRST INFLATION AT AROUND 14 ATMOSPHERES. THE BDC WAS REMOVED WITHOUT RESISTANCE AND A 3.25X12 MM NC TREK BDC WAS USED TO CONTINUE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
76785 NC TREK CORONARY DILATATION CATHETER CORONARY DILATATION CATHETER LOX AV-TEMECULA-CT 71130G1 08717648151910

Patients

Seq Age Sex Outcome Treatment
1